Acquisitive
point-of-care diagnostics firm EKF Diagnostics has launched EKF Molecular
Diagnostics to focus on molecular and companion diagnostics. Its new subsidiary has acquired 360 Genomics
a pre-revenue but close to commercialisation business that develops diagnostic
technology and, in addition, Andrew Webb has joined EKF as chief executive of
the business.
Penny Winter – The UK Knack Group
